Abstract：
Metabolic syndrome is a disease the World Health Organization has called a new pandemic of the 21st century. Arterial hypertension is one of the criteria for this diagnosis and a determinant of damage to major target organs. The present clinical case demonstrates an experience of treatment of arterial hypertension associated with metabolic syndrome with a valsartan/sacubitril molecular complex.
摘要：
代谢综合征是一种被世界卫生组织称为21世纪新大流行的疾病。动脉高血压是这种诊断的标准之一，也是主要靶器官损害的决定因素。本临床病例证明了用缬沙坦/沙库巴曲分子复合物治疗与代谢综合征相关的动脉高血压的经验。
